| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 6 | |
| #2 | United States | 5 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Hong Kong | 1 | |
| #6 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Environmental technology | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies | |
| #6 | Enzymes | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Heemskerk Mirjam H M | 10 |
| #2 | Falkenburg J H Frederik | 10 |
| #3 | Offringa Rienk | 2 |
| #4 | Toes Rene | 1 |
| #5 | Franken Cornelus Leonardus Maria Coleta | 1 |
| #6 | Klein Michel Robert | 1 |
| #7 | James Terrence William | 1 |
| #8 | Melief Cornelis Johannes Maria | 1 |
| #9 | Mierlo Geertje Van | 1 |
| #10 | Leyten Eliane Madeleine Sophie | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3268014A2 | T-cell receptors directed against the preferentially expressed antigen of melanoma and uses thereof | |
| US2014154265A1 | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity | |
| AU2006229549A1 | Methods and means for diagnostics, prevention and treatment of Mycobacterium infections and tuberculosis disease |